Altria Group and its tobacco operating companies actively supported legislation that gave the Food and Drug Administration (FDA) authority to regulate tobacco products.
Under the 2009 Family Smoking Prevention and Tobacco Control Act, FDA has authority to regulate cigarettes, cigarette tobacco, "roll-your-own" tobacco and smokeless tobacco products. On May 10, 2016, FDA published a Final Rule to extend the Agency's authority to regulate other tobacco products, including cigars, e-vapor products, and other products containing tobacco-derived nicotine.
Thoughtfully implementing this regulation could help resolve many of the complex issues that surround tobacco products and provide significant benefits to adult consumers by:
- Establishing a common set of high standards for all tobacco manufacturers and importers doing business in the United States; and
- Creating clear principles for accurate, science- and evidence-based communications about tobacco products to consumers.
We also supported the legislation because it gave the FDA the authority to evaluate tobacco products that could be lower risk. The agency has the tools and scientific expertise to assess potentially reduced-risk tobacco products and the law creates pathways for appropriate communications about lower-risk products.
Development of, and appropriate communications about, lower-risk tobacco products should be part of a comprehensive harm-reduction strategy that complements proven prevention and cessation strategies, not competes with them. Developing a comprehensive harm-reduction strategy is among the most meaningful actions the FDA can take to reduce the health effects of tobacco use.
Adults who use tobacco products have the right to objective information about the relative risk of tobacco products to make informed choices, and the FDA has the authority to determine how such information is communicated.
For those who continue to use tobacco, there is a growing body of evidence that suggests some tobacco products are less risky than others. We continue to engage and share our science with the FDA and others in public health about tobacco harm reduction.
To learn more, including milestones, our positions and regulatory filings, visit the Federal Regulation of Tobacco
Altria's tobacco operating companies support two websites: